90Y-ibritumomab tiuxetan

{
  "id": "MLC-T-ONC-000080",
  "term": "90Y-ibritumomab tiuxetan",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. 90Y-ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. 90Y-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 90Y-Zevalin, IDEC-Y2B8, and yttrium Y 90-ibritumomab tiuxetan.",
  "synonyms": [
    "90Y-Zevalin",
    "IDEC-Y2B8",
    "yttrium Y 90-ibritumomab tiuxetan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/90y-ibritumomab-tiuxetan/"
}